View in EDS HTML Full Text PDF Full Text

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Saved in:
Bibliographic Details
Title: Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Authors: Kittai AS; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adam.kittai@mssm.edu., Huang Y; Division of Hematology, The Ohio State University, Columbus, OH, USA., Miller S; Division of Hematology, The Ohio State University, Columbus, OH, USA., Allan JN; Weill Cornell Medicine, New York, NY, USA., Bhat SA; Division of Hematology, The Ohio State University, Columbus, OH, USA., Bond DA; Division of Hematology, The Ohio State University, Columbus, OH, USA., Brander DM; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Duke Cancer Institute, Durham, NC, USA., Byrd JC; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Chong E; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Danilov AV; City of Hope National Medical Center, Duarte, CA, USA., Ding W; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dowling MR; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Dvorak-Kornaus K; Division of Hematology, The Ohio State University, Columbus, OH, USA., Freedman H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Hampel PJ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Ho C; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Hwang SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Islam P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Malakhov N; Weill Cornell Medicine, New York, NY, USA., Matasar M; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA., Miller C; Division of Pathology, The Ohio State University, Columbus, OH, USA., Omer Z; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA., Parikh SA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Parry E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Rabe KG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Raess PW; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA., Rai M; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Roeker L; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rhodes J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA., Rogers KA; Division of Hematology, The Ohio State University, Columbus, OH, USA., Saha A; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Schade J; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA., Scott HW; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia., Shadman M; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Shouse G; City of Hope National Medical Center, Duarte, CA, USA., Skarbnik A; Novant Health Cancer Institute, Lymphoma and CLL/SLL Program, Charlotte, NC, USA., Spurgeon S; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Stephens DM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA., Thompson MC; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thompson PA; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Yano M; The Ohio State University College of Medicine, Columbus, OH, USA., Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH, USA.
Source: Blood cancer journal [Blood Cancer J] 2025 Feb 20; Vol. 15 (1), pp. 23. Date of Electronic Publication: 2025 Feb 20.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39979241
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kittai+AS%22">Kittai AS</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Adam.kittai@mssm.edu.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Miller+S%22">Miller S</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Allan+JN%22">Allan JN</searchLink>; Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bhat+SA%22">Bhat SA</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Bond+DA%22">Bond DA</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Brander+DM%22">Brander DM</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Duke Cancer Institute, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Byrd+JC%22">Byrd JC</searchLink>; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Chavez+JC%22">Chavez JC</searchLink>; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Chong+E%22">Chong E</searchLink>; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Davids+MS%22">Davids MS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Danilov+AV%22">Danilov AV</searchLink>; City of Hope National Medical Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ding+W%22">Ding W</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Dowling+MR%22">Dowling MR</searchLink>; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Dvorak-Kornaus+K%22">Dvorak-Kornaus K</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Freedman+H%22">Freedman H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hampel+PJ%22">Hampel PJ</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Ho+C%22">Ho C</searchLink>; Division of Medical Oncology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Hwang+SR%22">Hwang SR</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Islam+P%22">Islam P</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Malakhov+N%22">Malakhov N</searchLink>; Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Matasar+M%22">Matasar M</searchLink>; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Miller+C%22">Miller C</searchLink>; Division of Pathology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Omer+Z%22">Omer Z</searchLink>; Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.<br /><searchLink fieldCode="AU" term="%22Parikh+SA%22">Parikh SA</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Parry+E%22">Parry E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rabe+KG%22">Rabe KG</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Raess+PW%22">Raess PW</searchLink>; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Rai+M%22">Rai M</searchLink>; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Roeker+L%22">Roeker L</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Rhodes+J%22">Rhodes J</searchLink>; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Rogers+KA%22">Rogers KA</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Saha+A%22">Saha A</searchLink>; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Schade+J%22">Schade J</searchLink>; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Scott+HW%22">Scott HW</searchLink>; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Shadman+M%22">Shadman M</searchLink>; Division of Medical Oncology, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Shouse+G%22">Shouse G</searchLink>; City of Hope National Medical Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Skarbnik+A%22">Skarbnik A</searchLink>; Novant Health Cancer Institute, Lymphoma and CLL/SLL Program, Charlotte, NC, USA.<br /><searchLink fieldCode="AU" term="%22Spurgeon+S%22">Spurgeon S</searchLink>; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Stephens+DM%22">Stephens DM</searchLink>; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+MC%22">Thompson MC</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+PA%22">Thompson PA</searchLink>; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Yano+M%22">Yano M</searchLink>; The Ohio State University College of Medicine, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Woyach+JA%22">Woyach JA</searchLink>; Division of Hematology, The Ohio State University, Columbus, OH, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Feb 20; Vol. 15 (1), pp. 23. <i>Date of Electronic Publication: </i>2025 Feb 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39979241
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-025-01236-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 23
    Titles:
      – TitleFull: Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kittai AS
      – PersonEntity:
          Name:
            NameFull: Huang Y
      – PersonEntity:
          Name:
            NameFull: Miller S
      – PersonEntity:
          Name:
            NameFull: Allan JN
      – PersonEntity:
          Name:
            NameFull: Bhat SA
      – PersonEntity:
          Name:
            NameFull: Bond DA
      – PersonEntity:
          Name:
            NameFull: Brander DM
      – PersonEntity:
          Name:
            NameFull: Byrd JC
      – PersonEntity:
          Name:
            NameFull: Chavez JC
      – PersonEntity:
          Name:
            NameFull: Chong E
      – PersonEntity:
          Name:
            NameFull: Davids MS
      – PersonEntity:
          Name:
            NameFull: Danilov AV
      – PersonEntity:
          Name:
            NameFull: Ding W
      – PersonEntity:
          Name:
            NameFull: Dowling MR
      – PersonEntity:
          Name:
            NameFull: Dvorak-Kornaus K
      – PersonEntity:
          Name:
            NameFull: Freedman H
      – PersonEntity:
          Name:
            NameFull: Hampel PJ
      – PersonEntity:
          Name:
            NameFull: Ho C
      – PersonEntity:
          Name:
            NameFull: Hwang SR
      – PersonEntity:
          Name:
            NameFull: Islam P
      – PersonEntity:
          Name:
            NameFull: Malakhov N
      – PersonEntity:
          Name:
            NameFull: Matasar M
      – PersonEntity:
          Name:
            NameFull: Miller C
      – PersonEntity:
          Name:
            NameFull: Omer Z
      – PersonEntity:
          Name:
            NameFull: Parikh SA
      – PersonEntity:
          Name:
            NameFull: Parry E
      – PersonEntity:
          Name:
            NameFull: Rabe KG
      – PersonEntity:
          Name:
            NameFull: Raess PW
      – PersonEntity:
          Name:
            NameFull: Rai M
      – PersonEntity:
          Name:
            NameFull: Roeker L
      – PersonEntity:
          Name:
            NameFull: Rhodes J
      – PersonEntity:
          Name:
            NameFull: Rogers KA
      – PersonEntity:
          Name:
            NameFull: Saha A
      – PersonEntity:
          Name:
            NameFull: Schade J
      – PersonEntity:
          Name:
            NameFull: Scott HW
      – PersonEntity:
          Name:
            NameFull: Shadman M
      – PersonEntity:
          Name:
            NameFull: Shouse G
      – PersonEntity:
          Name:
            NameFull: Skarbnik A
      – PersonEntity:
          Name:
            NameFull: Spurgeon S
      – PersonEntity:
          Name:
            NameFull: Stephens DM
      – PersonEntity:
          Name:
            NameFull: Thompson MC
      – PersonEntity:
          Name:
            NameFull: Thompson PA
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Yano M
      – PersonEntity:
          Name:
            NameFull: Woyach JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2025 Feb 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1